Obstructive Sleep Apnea and Commercial Driving
A 45-year-old male long-haul truck driver presents with excessive daytime sleepiness. He reports falling asleep at the wheel twice in the past month. His Epworth Sleepiness Scale score is 18/24. He has a BMI of 34 kg/m², neck circumference 17.5 inches, and a history of hypertension. He undergoes a home sleep apnea test that shows an apnea-hypopnea index (AHI) of 32 events/hour with significant oxygen desaturation. He is diagnosed with severe obstructive sleep apnea (OSA). He is eager to start treatment and return to work immediately.
1. What is the most appropriate next step in management regarding his fitness to drive?
Read the worked answer
This patient has severe OSA with excessive daytime sleepiness and a history of falling asleep while driving, which poses a significant public safety risk. According to guidelines (e.g., from the American Thoracic Society and Federal Motor Carrier Safety Administration), he should not drive until his OSA is effectively treated and symptoms are controlled. The next step is to initiate positive airway pressure (PAP) therapy and provide education about the importance of adherence. He should be advised not to drive until he has been on effective therapy for a sufficient period (often at least 2 weeks) and symptoms have resolved, with documentation of adherence and efficacy. Therefore, the most appropriate step is to start PAP therapy and counsel him to refrain from driving until control is achieved.
2. How would you assess the effectiveness of therapy and determine when he can resume driving?
Read the worked answer
Effectiveness of PAP therapy should be assessed by both subjective and objective measures. Subjectively, the patient's daytime sleepiness should improve (e.g., Epworth Sleepiness Scale < 10). Objectively, adherence to PAP should be documented (e.g., usage >4 hours per night on 70% of nights) and efficacy should be confirmed by a follow-up sleep study or PAP device data showing reduction in AHI (e.g., AHI < 5 or < 10 with resolution of symptoms). Once these criteria are met and the patient feels alert, he may resume driving. Regular follow-up is necessary to ensure continued adherence and symptom control. Thus, resumption of driving is contingent on documented adherence and efficacy, along with symptom improvement.